Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell AbCellera Biologics Inc (ABCL) – AbCellera Biologics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbCellera Biologics (ABCL) trades at $5.075, down 9.7% on the day, as the biotech company continues its transition from partner-based antibody discovery to proprietary drug development. Despite negative profitability metrics with a -181.74% net income margin, the company maintains strong analyst support with 82% buy ratings and a $9.00 consensus price target representing 77% upside potential. Recent technical indicators show a bullish moving average crossover while the company progresses its lead clinical program ABCL635 through Phase 1 trials.
The investment case hinges on AbCellera's pipeline transition success, with positive Phase 1 data for ABCL635 providing near-term catalysts. However, persistent cash burn and negative earnings pose significant risks. Wall Street remains optimistic about the company's long-term prospects despite current financial challenges, viewing the current valuation as an opportunity for growth-oriented investors willing to accept biotech development risks.
Read full analysis

Key Stats

  • Market Cap
    $1.66B
  • Sector
    Health
  • 3M Drawdown
    -22.86%
  • Enterprise Value
    $1.29B
  • Dividend Yield
    -
  • Trading Activity
    93% Buy | 7% Sell
  • Typical Hold Time
    39 days
$5.28
52W Low: $2.51
09 Jun 2025
52W High: $6.46
01 Jun 2026

AbCellera Biologics Inc (ABCL) is currently valued at a market capitalization of $1.66B, with an enterprise value of $1.29B. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.51 and a high of $6.46, highlighting its annual price range. Over the past three months, AbCellera Biologics Inc has recorded a drawdown of -22.86%, reflecting recent price volatility. On average, investors hold AbCellera Biologics Inc for approximately 39 days, indicating typical investor behavior on the platform.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.66B
  • Sector
    Health
  • 3M Drawdown
    -22.86%
  • Enterprise Value
    $1.29B
  • Dividend Yield
    -
  • Trading Activity
    93% Buy | 7% Sell
  • Typical Hold Time
    39 days
$5.28
52W Low: $2.51
09 Jun 2025
52W High: $6.46
01 Jun 2026

AbCellera Biologics Inc (ABCL) is currently valued at a market capitalization of $1.66B, with an enterprise value of $1.29B. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.51 and a high of $6.46, highlighting its annual price range. Over the past three months, AbCellera Biologics Inc has recorded a drawdown of -22.86%, reflecting recent price volatility. On average, investors hold AbCellera Biologics Inc for approximately 39 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!